Clinical trial · Observational
Specific Methylation Profiles in HNSCC
Validation of Specific Methylation Profiles Ind Head and Neck Cancer - a Cohort Study
NCT04567056CI-TRIAL-00085622recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In the study, N-20190047, the investigators aim to define specific methylation patterns in a group of patients with head and neck squamous cell carcinomas. With this study the investigators aim to validate these findings in a larger cohort.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Squamous Cell Carcinoma | Head and Neck Squamous Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood sample | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Cancer group
- description
- Patients with verified head and neck squamous cell carcinomas
- interventionNames
- Diagnostic Test: Blood sample
- label
- Control group
- description
- Matched control group without active or earlier cancer and a normal ENT examination.
- interventionNames
- Diagnostic Test: Blood sample
Primary outcomes (1)
- measure
- Diagnostic accuracy
- timeFrame
- At diagnosis
- description
- How accurate can the methylation profiles diagnose the head and neck squamous cell carcinoma
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Cancer group: Inclusion Criteria: * Written informed consent * Verified head and neck squamous cell carcinoma Exclusion Criteria: * Other active cancer * Uncontrolled comorbidity * Unable to give informed consent Control group: Inclusion Criteria: * Written informed consent * Normal ENT-examination Exclusion Criteria: * Other active cancer * Uncontrolled comorbidity * Unable to give informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.